Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionCadinha & Co Llc
Latest Disclosed Ownership5,195 shares
Latest Disclosed Value $ 1,827,861
Cadinha & Co Llc reports 0.48% increase in ownership of AMGN / Amgen Inc.

On May 11, 2026 - Cadinha & Co Llc filed a 13F-HR form disclosing ownership of 5,195 shares of Amgen Inc. (CH:AMGN) valued at $1,827,861 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 5,170 shares of Amgen Inc.. This represents a change in shares of 0.48% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F Amgen COM 031162100 5,195 25 0.48 1,828 7.98 0.3405
2026-01-28 2025-12-31 13F Amgen COM 031162100 5,170 100 1.97 1,692 18.32 0.2611
2025-10-17 2025-09-30 13F Amgen COM 031162100 5,070 25 0.50 1,431 1.56 0.1945
2025-07-31 2025-06-30 13F Amgen COM 031162100 5,045 -62 -1.21 1,409 -11.50 0.2337
2025-04-04 2025-03-31 13F Amgen COM 031162100 5,107 -110 -2.11 1,591 17.07 0.3418
2025-01-16 2024-12-31 13F Amgen COM 031162100 5,217 8 0.15 1,360 -19.01 0.2256
2024-10-09 2024-09-30 13F Amgen COM 031162100 5,209 32 0.62 1,678 3.77 0.2869
2024-07-31 2024-06-30 13F Amgen COM 031162100 5,177 167 3.33 1,618 13.55 0.3000
2024-05-02 2024-03-31 13F Amgen COM 031162100 5,010 0 0.00 1,424 -1.25 0.2448
2024-01-24 2023-12-31 13F Amgen COM 031162100 5,010 -875 -14.87 1,443 -8.79 0.2303
2023-11-02 2023-09-30 13F Amgen COM 031162100 5,885 970 19.74 1,582 44.91 0.3498
2023-07-26 2023-06-30 13F Amgen COM 031162100 4,915 -26,663 -84.44 1,091 -85.71 0.1984
2023-04-28 2023-03-31 13F Amgen COM 031162100 31,578 -28,028 -47.02 7,634 -51.23 2.1026
2023-01-25 2022-12-31 13F Amgen COM 031162100 59,606 52,526 741.89 15,655 880.83 3.4957
2022-10-21 2022-09-30 13F Amgen COM 031162100 7,080 0 0.00 1,596 -7.37 0.5371
2022-08-05 2022-06-30 13F Amgen COM 031162100 7,080 -1,120 -13.66 1,723 -13.11 0.3851
2022-05-12 2022-03-31 13F Amgen COM 031162100 8,200 -1,190 -12.67 1,983 -6.11 0.2856
2022-02-03 2021-12-31 13F Amgen COM 031162100 9,390 -72,315 -88.51 2,112 -87.84 0.2842
2021-11-12 2021-09-30 13F Amgen COM 031162100 81,705 1,059 1.31 17,375 -11.61 2.4818
2021-07-29 2021-06-30 13F Amgen COM 031162100 80,646 1,138 1.43 19,657 -0.63 2.6442
2021-05-06 2021-03-31 13F Amgen COM 031162100 79,508 -5,965 -6.98 19,782 0.66 2.8469
2021-01-22 2020-12-31 13F Amgen COM 031162100 85,473 1,821 2.18 19,652 -7.57 2.7222
2020-10-30 2020-09-30 13F Amgen COM 031162100 83,652 1,443 1.76 21,261 9.65 3.6916
2020-07-22 2020-06-30 13F Amgen COM 031162100 82,209 2,434 3.05 19,390 19.89 3.2970
2020-05-06 2020-03-31 13F Amgen COM 031162100 79,775 72,714 1,029.80 16,173 850.24 4.2938
2020-01-23 2019-12-31 13F Amgen COM 031162100 7,061 65 0.93 1,702 25.70 0.2403
2019-10-30 2019-09-30 13F Amgen COM 031162100 6,996 -244 -3.37 1,354 1.50 0.2191
2019-08-09 2019-06-30 13F Amgen COM 031162100 7,240 -70,408 -90.68 1,334 -90.96 0.2411
2019-05-08 2019-03-31 13F Amgen COM 031162100 77,648 1,817 2.40 14,752 -0.07 2.8879
2019-01-29 2018-12-31 13F Amgen COM 031162100 75,831 53,345 237.24 14,762 216.71 3.6624
2018-11-07 2018-09-30 13F Amgen COM 031162100 22,486 20 0.09 4,661 12.39 0.7370
2018-08-07 2018-06-30 13F Amgen COM 031162100 22,466 7,175 46.92 4,147 59.07 0.7589
2018-05-10 2018-03-31 13F Amgen COM 031162100 15,291 -29,829 -66.11 2,607 -66.77 0.5260
2018-01-27 2017-12-31 13F Amgen COM 031162100 45,120 32,334 252.89 7,846 229.11 1.0838
2017-11-14 2017-09-30 13F Amgen COM 031162100 12,786 1,500 13.29 2,384 22.63 0.4064
2017-08-02 2017-06-30 13F Amgen COM 031162100 11,286 1,950 20.89 1,944 26.89 0.3390
2017-05-09 2017-03-31 13F Amgen COM 031162100 9,336 100 1.08 1,532 13.48 0.3032
2017-02-10 2016-12-31 13F Amgen COM 031162100 9,236 -200 -2.12 1,350 -14.23 0.2321
2016-11-11 2016-09-30 13F Amgen COM 031162100 9,436 0 0.00 1,574 9.61 0.3205
2016-08-06 2016-06-30 13F Amgen COM 031162100 9,436 0 0.00 1,436 1.48 0.3078
2016-05-05 2016-03-31 13F Amgen COM 031162100 9,436 936 11.01 1,415 2.54 0.3646
2016-01-29 2015-12-31 13F Amgen COM 031162100 8,500 2,200 34.92 1,380 58.44 0.3272
2015-10-28 2015-09-30 13F Amgen COM 031162100 6,300 -49 -0.77 871 -10.67 0.2114
2015-07-28 2015-06-30 13F Amgen COM 031162100 6,349 49 0.78 975 -3.18 0.1942
2015-04-08 2015-03-31 13F Amgen COM 031162100 6,300 6,300 0.00 1,007 0.2004
2015-02-03 2014-12-31 13F Amgen COM 031162100 0 -6,300 -100.00 0 -100.00
2014-11-10 2014-09-30 13F Amgen COM 031162100 6,300 -20 -0.32 885 18.32 0.1610
2014-08-08 2014-06-30 13F Amgen COM 031162100 6,320 -400 -5.95 748 -9.77 0.1263
2014-04-29 2014-03-31 13F Amgen COM 031162100 6,720 0 0.00 829 8.08 0.1496
2014-01-31 2013-12-31 13F Amgen COM 031162100 6,720 -100 -1.47 767 0.52 0.1424
2013-10-31 2013-09-30 13F Amgen COM 031162100 6,820 0 0.00 763 13.37 0.1530
2013-08-07 2013-06-30 13F Amgen COM 031162100 6,820 6,820 673 0.1539
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.